Prophylaxis and Therapy for Chikungunya Virus Infection
Thérèse Couderc(Inserm), Marc Lecuit(Inserm), Marc Grandadam(Institut Pasteur), Nassirah Khandoudi(LFB (France)), Nicolas Gangneux(Inserm), Sébastien Bagot(LFB (France)), Jean‐François Prost(Lyon 1 Université), Catherine Visse(LFB (France))
Cited by 242
Related Papers
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
|PLoS Pathogens|2008|610
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion
|PLoS Medicine|2008|511
Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
|PLoS neglected tropical diseases|2013|494
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
|Journal of Clinical Investigation|1998|389